Compare AMRN & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRN | SABA |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 240.1M |
| IPO Year | 1993 | N/A |
| Metric | AMRN | SABA |
|---|---|---|
| Price | $14.36 | $8.66 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 80.9K | ★ 290.0K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $3.64 |
| 52 Week High | $20.90 | $4.42 |
| Indicator | AMRN | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 43.30 |
| Support Level | $13.64 | $8.62 |
| Resistance Level | $14.67 | $8.79 |
| Average True Range (ATR) | 0.74 | 0.14 |
| MACD | -0.15 | -0.00 |
| Stochastic Oscillator | 24.21 | 14.29 |
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.